| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
VYNE sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 426.6K | $277.6K | - | |
| Other | 118.4K | $77.1K | - | |
| Other | 111.3K | $72.5K | - | |
| CFO | 74.9K | $67.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 6, 2021 | Perceptive Advisors LLC51 | 10% Owner | Sell | 1,000,000 | $3.67 | $3,670,000.00 | -14.8% | -25.0% | -88.5% | |
| Mar 15, 2021 | Lepore Patrick G | Director | Buy | 12,500 | $7.41 | $92,562.50 | +100.0% | -47.9% | -92.3% | |
| Jan 28, 2021 | Perceptive Advisors LLC51 | 10% Owner | Buy | 4,219,409 | $2.37 | $9,999,999.33 | +18.4% | - | - | |
| Dec 3, 2020 | Lepore Patrick G | Director | Buy | 50,000 | $1.71 | $85,425.00 | New | - | - | |
| Sep 8, 2020 | Domzalski David | President and CEO | Buy | 75,000 | $1.38 | $103,567.50 | +6.0% | - | - | |
| Sep 8, 2020 | Saik Andrew | Chief Financial Officer | Buy | 40,000 | $1.46 | $58,480.00 | +13.3% | - | - | |
| Jun 9, 2020 | Perceptive Advisors LLC51 | 10% Owner | Buy | 2,702,702 | $1.85 | $4,999,998.70 | +13.4% | - | - | |
| Jul 24, 2018 | Presidio Partners 2007 Gp, L.P. | Former 10% Owner | Sell | 500,000 | $7.65 | $3,825,000.00 | -91.1% | - | - | |
| Jan 25, 2018 | Cha Albert | Director | Buy | 294,118 | $17.00 | $5,000,006.00 | -113.8% | - | - | |
| Jan 25, 2018 | Vivo Capital Viii, LLC57 | 10% Owner | Buy | 294,118 | $17.00 | $5,000,006.00 | -113.8% | - | - |